Serum Opacity Factor Unmasks Human Plasma High-Density Lipoprotein Instability via Selective Delipidation and Apolipoprotein A-I Desorption
Open Access
- 17 October 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 46 (45) , 12968-12978
- https://doi.org/10.1021/bi701525w
Abstract
Human plasma high-density lipoproteins (HDL) are important vehicles in reverse cholesterol transport, the cardioprotective mechanism by which peripheral tissue-cholesterol is transported to the liver for disposal. HDL is the target of serum opacity factor (SOF), a substance produced by Streptococcus pyogenes that turns mammalian serum cloudy. Using a recombinant (r) SOF, we studied opacification and its mechanism. rSOF catalyzes the partial disproportionation of HDL into a cholesteryl ester-rich microemulsion (CERM) and a new HDL-like particle, neo HDL, with the concomitant release of lipid-free (LF)-apo A-I. Opacification is unique; rSOF transfers apo E and nearly all neutral lipids of ∼100,000 HDL particles into a single large CERM whose size increases with HDL-CE content (r ∼100−250 nm) leaving a neo HDL that is enriched in PL (41%) and protein (48%), especially apo A-II. rSOF is potent; within 30 min at 37 °C, 10 nM rSOF opacifies 4 μM HDL. At respective low and high physiological HDL concentrations, LF-apo A-I is monomeric and tetrameric. CERM formation and apo A-I release have similar kinetics suggesting parallel or rapid sequential steps. According to the reaction products and kinetics, rSOF is a heterodivalent fusogenic protein that uses a docking site to displace apo A-I and bind to exposed CE surfaces on HDL; the resulting rSOF−HDL complex recruits additional HDL with its binding-delipidation site and through multiple fusion steps forms a CERM. rSOF may be a clinically useful and novel modality for improving reverse cholesterol transport. With apo E and a high CE content, CERM could transfer large amounts of cholesterol to the liver for disposal via the LDL receptor; neo HDL is likely a better acceptor of cellular cholesterol than HDL; LF-apo A-I could enhance efflux via the ATP-binding casette transporter ABCA1.Keywords
This publication has 43 references indexed in Scilit:
- Next-Generation Dengue Vaccines: Novel Strategies Currently Under DevelopmentViruses, 2011
- Speciation of Human Plasma High-Density Lipoprotein (HDL): HDL Stability and Apolipoprotein A-I PartitioningBiochemistry, 2007
- Detergent-Mediated Phospholipidation of Plasma Lipoproteins Increases HDL Cholesterophilicity and Cholesterol Efflux via SR-BIBiochemistry, 2006
- Remodeling of Human Plasma Lipoproteins by Detergent PerturbationBiochemistry, 2005
- Microsomal triglyceride transfer protein expression in adipocytes: A new component in fat metabolismFEBS Letters, 2005
- Measurement and prediction of the rates of spontaneous transfer of phospholipids between plasma lipoproteinsPublished by Elsevier ,2002
- Relationship between Expression Levels and Atherogenesis in Scavenger Receptor Class B, Type I TransgenicsPublished by Elsevier ,2000
- Microsomal triglyceride transfer proteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1997
- Molecular and Macromolecular Specificity of Human Plasma Phospholipid Transfer ProteinBiochemistry, 1997
- Trichodermin, a possible inhibitor of the termination process of protein synthesisJournal of Cellular Physiology, 1973